Stickied 2025

Medical conditions associated with gender dysphoria (2025)

Doctors and researchers have observed that many people with gender dysphoria share a cluster of medical conditions tied to atypical estrogen signaling (high or low) at birth. This observation suggests a biological intersex condition for a subgroup of individuals, distinguishing their experience from the framing of gender dysphoria as a purely psychiatric phenomenon.

For a full overview please see the wiki: Medical conditions associated with gender dysphoria.

2025 Update:
Based on published research and clinical observations, a specific biological hypothesis has emerged: that the common intersection of medical conditions for a subgroup of individuals with gender dysphoria is tied to the production, metabolism, or activation of the estrogen receptor.

While other genetic factors can influence estrogen signaling, the CYP1B1 and CYP1A1/CYP1A2 genes, which are responsible for breaking down estrogen, have become key players and are often the first genes looked at. These genes, once thought to only play a minor role in a rapid metabolic process, can significantly alter hormone balance especially when their variants are paired with other mutations, particularly those that result in reduced COMT activity. While the individual components of these pathways are well-studied, their combined effect represents a novel and crucial insight. You can find more details on the Estrogen Metabolism wiki page.

Better Care

This simple awareness of these interconnected conditions has already helped people improve their own health and lead to better transition outcomes. It has provided a starting point for previously unsolvable mysterious edge cases and empowered individuals to take charge of their health.

Improved Clinical Management

• Non-Classic Congenital Adrenal Hyperplasia (NCAH): Some women with NCAH often show elevated adrenal androgens such as DHT and 11-oxygenated androgens. This NCAH can interfere with feminization, cause anxiety, dizziness on standing ("POTS-like" symptoms), and other issues. Getting proper diagnosing and then targeted adrenal support can reduce comorbid symptoms such as excess androgen.
• Challenges with Feminization: Some women struggle to feminize despite high estrogen levels. Addressing any metabolism issues (COMT support, methylation, low magnesium, etc.) can sometimes help with this issue as well as other health problems associated with low estrogen signaling such as constipation.
• Challenges with Masculinization: Some transgender men fail to masculinize as expected because they rapidly convert testosterone into estrogen or have high levels of high-affinity estrogens. Recognizing that this is a possibility can lead to getting lab work and supportive treatments like aromatase inhibitors or COMT cofactor support to increase inactivation of high-affinity estrogen when that is the issue.
• Addressing Rare Conditions: With the understanding of what typically goes on, when encountering outlier cases, clinicians (Dr. Powers and others) knows where to look and is much more likely to be able to identify genetic issues such as reduced STS enzyme or Estrogen Insensitivity Syndrome (EIS), and possibly work around them, something that would have been impossible a decade ago.

Diagnostic Clarity and Preventing Regret

• Inverted Sex Hormone Signaling: Individuals with the genetic profile for inverted sex hormone signaling are given autonomy to first resolve their underlying endocrine issues before undergoing HRT. In some of these cases, medical or social transition may no longer feel necessary or desired. This outcome upholds patient autonomy by ensuring they have all the information needed to pursue the most suitable path for them.
• Avoiding Misdiagnosis: For individuals who don’t match the expected phenotypes or hormonal signaling patterns, further investigation can sometimes lead to alternative, more appropriate diagnoses. This process ensures individuals receive the most effective care for their specific needs, supporting them in making the most informed decisions about their well-being and helping to prevent potentially regretful outcomes.

Autonomy, Identity, and Sexuality Support

• AMAB people who have Congenital Copulatory Role Discordance (CCRD) and low estrogen signaling who don’t wish to transition, may still need a minimal level of estrogen for overall health and well-being as they age.
• For those wanting to try every other option first, understanding their individual biology allows for supportive interventions that rarely, but occasionally, are enough to reduce dysphoria.
• For individuals considering HRT, this framework allows folks here to share what happened to them so others with similar phenotypes can know what might be common patterns, especially around sexuality post-transition. While historically it was nearly unknown what would happen, this helps those be better informed about possible outcomes if they go on HRT, such as becoming bisexual, or switching from gynephilic to androphilic, or vice versa. To be clear, this still needs a formal study, and is only a noted anecdotal pattern.

Managing Comorbid Conditions

• Many experience comorbid conditions such as ADHD symptoms, poor sleep, hypermobility-related pain, IBS, or inflammatory bowel disease-like flares. Watching for, identifying, and addressing any underlying endocrine imbalances through known methods can sometimes lead to a subtle or dramatic improvement in these conditions.

A Note on Vitamin D deficiency

And if you are reading this, please do get your Vitamin D level checked! Due to both genetic factors and lifestyle (e.g., lack of sun exposure), Vitamin D deficiency is a common and easily correctable condition.

A Call for Further Research

This hypothesis is based on a combination of existing published research, clinical observations, and reported data from individuals. While these insights have provided a valuable framework it does not yet represent a complete picture. The hypothesis has reached a maturity stage where future research can be more targeted to areas with the highest probability of success. Further formal studies are needed to validate and expand upon these findings, including larger sample sizes of existing work, formal replication, and the publishing of edge cases as case studies.

Thanks to everyone who has helped

The progress made in this area is a collective achievement. When we started we had a list of common conditions, many of whose connection was initially a mystery. The progress we have made so far would not have been possible without the contributions of so many, from researching medical conditions, reading papers, investigating personal DNA, to reviewing and refining the wiki. Thank you to everyone who continues to contribute their time, data, questions, and insight. We welcome continued feedback to keep improving.

For a comprehensive overview, please see the full wiki: Medical conditions associated with gender dysphoria.